Approvals/TGA/KADCYLA trastuzumab emtansine (rch) 160 mg powder for injection vial

Approved

STANDARD

KADCYLA trastuzumab emtansine (rch) 160 mg powder for injection vial

Roche Products Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: b1e2b8d449a6ebb2
Product Name: KADCYLA trastuzumab emtansine (rch) 160 mg powder for injection vial
Artg Id: 201622
Artg Name: KADCYLA trastuzumab emtansine (rch) 160 mg powder for injection vial
Sponsor: Roche Products Pty Ltd
Company Detail Path: /organization/roche-products-pty-ltd
Artg Date: 2013-09-03
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/a0525afc669956cba198eaf5f56f2af0.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/306181507497a65ff17626fde60d38d9.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

b1e2b8d449a6ebb2

Type

Standard